Herantis Pharma lands Nordic Stars Award
Finnish Herantis Pharma was announced as the winner of the Nordic Stars Award at the Nordic Life Sciences Days in Malmö, Sweden.
Herantis Pharma granted a US patent
The United States Patent and Trademark Office has issued a patent titled ‘Neurotrophic factor MANF and uses thereof’ to Finnish Herantis Pharma.
Helsinki institutions team up abroad for health
The Hospital District of Helsinki and Uusimaa (HUS) and the University of Helsinki are collaborating with Pfizer and GlaxoSmithKline through new partner contracts.
FIT Biotech and InnaVirVax to fight HIV
Finnish FIT Biotech and Paris-based InnaVirVax have commenced collaboration in HIV treatment that combines their proprietary immunotherapeutic HIV vaccines.
Orion and US university partner up against cancer
Finnish pharmaceutical and diagnostics company Orion has announced a collaboration with a US non-profit organisation in pursuit of new medicines for oncological diseases.
Herantis bags EUR 6 million for Parkinson’s study
Finnish pharmaceutical company Herantis Pharma has received funding from the research and innovation program of the European Union known as Horizon 2020.
Finnish sea buckthorn opens eyes in Europe
Finnish Aromtech and Piiloset have developed a sea buckthorn oil for treating dry eyes. The product will be available first in Europe and later elsewhere in the world.
Faron advances cancer immunotherapy with new co-operation
Finnish biopharmaceutical company Faron Pharmaceuticals has entered into an agreement with Swiss-based life science company Selexis.
Finnish spruce resin heals around the world
Spruce trees have a secret weapon: their resin fights off bacteria. Now these healing powers have been harnessed by Finland’s Repolar Pharmaceuticals and it is targeting international markets.
Biohit’s cancer preventative rolls out in Southeast Asia
Finnish biotechnology company Biohit has signed an agreement with Daiichi Sankyo (Thailand) for the exclusive distribution rights of Acetium capsules in Vietnam, Laos, Cambodia and Myanmar.
Biohit wins contract with Chinese Ministry of Health
Biohit’s GastroPanel biomarkers are to screen half a million 40–80-year-old asymptomatic persons in China, as part of gastric cancer risk screening study being organised in Chinese healthcare centres.